Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.1K
Phase II Conjugation Reactions: Overview01:14

Phase II Conjugation Reactions: Overview

249
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
249
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

3.9K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.9K
Prodrugs01:30

Prodrugs

2.7K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
2.7K
Principles of Drug Action01:24

Principles of Drug Action

6.2K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.2K
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids01:19

Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

303
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
303

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Covalent Modulation of Protein Misfolding and Aggregation Processes in the Context of Neurodegenerative Diseases.

Archiv der Pharmazie·2026
Same author

Probing Allosteric Kinase Modulators as Next Game-Changers in Fighting Neurodegeneration.

Journal of medicinal chemistry·2026
Same author

Exploration of the Neuromodulatory Properties of Fyn and GSK-3β Kinases Exploiting 7-Azaindole-Based Inhibitors.

Journal of medicinal chemistry·2025
Same author

Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011-2023.

Molecules (Basel, Switzerland)·2024
Same author

Double Attack to Oxidative Stress in Neurodegenerative Disorders: MAO-B and Nrf2 as Elected Targets.

Molecules (Basel, Switzerland)·2023
Same author

From Monoamine Oxidase Inhibition to Antiproliferative Activity: New Biological Perspectives for Polyamine Analogs.

Molecules (Basel, Switzerland)·2023

Related Experiment Video

Updated: Jul 27, 2025

Facile Protocol for the Synthesis of Self-assembling Polyamine-based Peptide Amphiphiles PPAs and Related Biomaterials
08:55

Facile Protocol for the Synthesis of Self-assembling Polyamine-based Peptide Amphiphiles PPAs and Related Biomaterials

Published on: June 25, 2018

8.1K

Polyamine-Drug Conjugates: Do They Boost Drug Activity?

Filippo Basagni1, Giambattista Marotta1, Michela Rosini1

  • 1Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy.

Molecules (Basel, Switzerland)
|June 10, 2023
PubMed
Summary

Conjugating polyamine tails to drugs enhances their effectiveness by improving cellular uptake. This review highlights polyamine conjugates for various therapeutic areas over the last decade.

Keywords:
antimicrobialantitumordrug conjugateneuroprotectivepolyamine

More Related Videos

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
09:12

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

6.9K
Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.0K

Related Experiment Videos

Last Updated: Jul 27, 2025

Facile Protocol for the Synthesis of Self-assembling Polyamine-based Peptide Amphiphiles PPAs and Related Biomaterials
08:55

Facile Protocol for the Synthesis of Self-assembling Polyamine-based Peptide Amphiphiles PPAs and Related Biomaterials

Published on: June 25, 2018

8.1K
Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
09:12

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods

Published on: May 11, 2018

6.9K
Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

6.0K

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Drug Delivery

Background:

  • Polyamines are crucial for cell function.
  • Elevated polyamine transport is observed in various diseases.
  • Conjugating polyamines to bioactive molecules enhances pharmacological profiles.

Purpose of the Study:

  • To review polyamine conjugates developed in the last decade.
  • To classify these conjugates by therapeutic area.
  • To highlight achievements and guide future polyamine conjugate development.

Main Methods:

  • Literature review of polyamine conjugates.
  • Classification based on therapeutic applications (anticancer, antimicrobial, antioxidant, neuroprotective).
  • Analysis of pharmacological enhancements attributed to polyamine conjugation.

Main Results:

  • Numerous polyamine conjugates have been developed for diverse therapeutic applications.
  • Polyamines facilitate enhanced cellular and subcellular uptake via transporter systems.
  • Conjugation strategies have successfully improved the efficacy of various bioactive agents.

Conclusions:

  • Polyamine conjugation is a validated strategy for improving drug delivery and efficacy.
  • Future research should focus on optimizing polyamine conjugates for specific pathological conditions.
  • The polyamine transporter system offers a promising target for drug delivery enhancement.